Your browser doesn't support javascript.
loading
Analysis of Clinical Application and Adverse Reactions of Scopolamine Butylbromide Injection / 中国药师
China Pharmacist ; (12): 867-870, 2018.
Article in Chinese | WPRIM | ID: wpr-705614
ABSTRACT

Objective:

To investigate and analyze the clinical application and adverse reactions of scopolamine butylbromide injection to promote the rational use in clinics.

Methods:

Totally 3695 effective cases treated with scopolamine butylbromide injection were collected from January 2016 to July 2017, and the age, sex, cause of drug use, medication days, combined use, high risk factors, and names, types and clinical manifestations of adverse reactions induced by scopolamine butylbromide were classified and statistically analyzed.

Results:

The overall incidence of adverse reactions of scopolamine butylbromide was 0.22%. The drug use rate was 44.36% in high-risk patients. The incidence of adverse drug reactions in high-risk patients was 1.83%,and that in low-risk patients was 0.24%, and the difference was 7.63 times. Combined drug use was common, and 1.98% of the combined use had potential drug interactions.

Conclusion:

The requirements of drug instructions should be strictly followed,and high-risk patients and drug combination should be paid much attention in order to reduce the risk of adverse drug reactions and ensure the drug safety.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Risk factors Language: Chinese Journal: China Pharmacist Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Risk factors Language: Chinese Journal: China Pharmacist Year: 2018 Type: Article